VisionGate Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Private

  • Employees
  • 24

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 1

VisionGate General Information

Description

Developer of a biotechnology platform designed to provide early detection of lung cancer through 3d cellular imaging and AI. The company offers a non-invasive lung cancer test that utilizes 3d cellular imaging and AI-powered detection to identify early-stage disease, featuring a proprietary platform that analyzes individual cells in high-resolution digital 3d from sputum samples, enabling high-risk patients to access early diagnostic screening without radiation exposure.

Contact Information

Website
www.visiongate3d.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 22121 17th Avenue South East
  • Suite E-114
  • Bothell, WA 98021
  • United States
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Artificial Intelligence & Machine Learning, HealthTech, Life Sciences
Corporate Office
  • 22121 17th Avenue South East
  • Suite E-114
  • Bothell, WA 98021
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

VisionGate Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Secondary Transaction - Private 30-May-2022 Completed Generating Revenue
9. Debt - PPP 27-Apr-2020 Completed Generating Revenue
8. Later Stage VC (Series A) 17-Dec-2019 Completed Generating Revenue
7. Accelerator/Incubator 14-Oct-2015 Completed Generating Revenue
6. Grant 06-Jan-2012 Completed Generating Revenue
5. Angel (individual) 21-Aug-2008 Completed Generating Revenue
4. Angel (individual) 24-Aug-2007 Completed Generating Revenue
3. Angel (individual) 05-Jul-2006 Completed Generating Revenue
2. Angel (individual) 01-Sep-2005 $784K $784K Completed Generating Revenue
1. University Spin-Out 01-Jan-2001 Completed Startup
To view VisionGate’s complete valuation and funding history, request access »

VisionGate Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A
To view VisionGate’s complete cap table history, request access »

VisionGate Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a biotechnology platform designed to provide early detection of lung cancer through 3d cellular imaging and
Biotechnology
Bothell, WA
24 As of 2023

Foster City, CA
 

Minneapolis, MN
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

VisionGate Competitors (45)

One of VisionGate’s 45 competitors is Adela, a Venture Capital-Backed company based in Foster City, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Adela Venture Capital-Backed Foster City, CA
Advanced Cell Diagnostics Formerly VC-backed Minneapolis, MN
Predicine Venture Capital-Backed Hayward, CA
Adaptive Biotechnologies Formerly VC-backed Seattle, WA
Freenome Formerly VC-backed Brisbane, CA
You’re viewing 5 of 45 competitors. Get the full list »

VisionGate Patents

  • 293

    Total Documents Applications and Grants

  • Total Patents Families

  • 130

    Granted

  • 14

    Pending

  • Expiring in next 12 mo

VisionGate Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260301173-A1 Ai-based method and system for detection of abnormal cells in urine Pending 28-Mar-2025
WO-2026207490-A1 Ai-based method and system for detection of abnormal cells in urine Pending 28-Mar-2025
US-20260301181-A1 Ai-based method and system for detection of circulating tumor cells in blood Pending 28-Mar-2025
WO-2026207493-A1 Ai-based method and system for detection of circulating tumor cells in blood Pending 28-Mar-2025
US-20260266723-A1 System and method for calibrating an optical imaging system Pending 06-Mar-2025 G01N21/6428
To view VisionGate’s complete patent history, request access »

VisionGate Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

VisionGate Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
University of Washington University
To view VisionGate’s complete investors history, request access »

Ready to get started?

Request a free trial

VisionGate FAQs

  • When was VisionGate founded?

    VisionGate was founded in 2001.

  • Where is VisionGate headquartered?

    VisionGate is headquartered in Bothell, WA.

  • What is the size of VisionGate?

    VisionGate has 24 total employees.

  • What industry is VisionGate in?

    VisionGate’s primary industry is Biotechnology.

  • Is VisionGate a private or public company?

    VisionGate is a Private company.

  • What is VisionGate’s current revenue?

    The current revenue for VisionGate is .

  • How much funding has VisionGate raised over time?

    VisionGate has raised $43.7M.

  • Who are VisionGate’s investors?

    University of Washington has invested in VisionGate.

  • Who are VisionGate’s competitors?

    Adela, Advanced Cell Diagnostics, Predicine, Adaptive Biotechnologies, and Freenome are some of the 45 competitors of VisionGate.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process